MA23779A1 - Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones - Google Patents

Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones

Info

Publication number
MA23779A1
MA23779A1 MA24134A MA24134A MA23779A1 MA 23779 A1 MA23779 A1 MA 23779A1 MA 24134 A MA24134 A MA 24134A MA 24134 A MA24134 A MA 24134A MA 23779 A1 MA23779 A1 MA 23779A1
Authority
MA
Morocco
Prior art keywords
alkoxyphenyl
purine
substitute
ones
compound
Prior art date
Application number
MA24134A
Other languages
English (en)
Inventor
Niewohner Ulrich
Perzborn Elisabeth
Bischoff Erwin
Schutz Helmuth
Schramm Matthias
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA23779A1 publication Critical patent/MA23779A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA24134A 1995-01-19 1996-01-18 Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones MA23779A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (1)

Publication Number Publication Date
MA23779A1 true MA23779A1 (fr) 1996-10-01

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24134A MA23779A1 (fr) 1995-01-19 1996-01-18 Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones

Country Status (30)

Country Link
US (1) US5866571A (fr)
EP (1) EP0722943A1 (fr)
JP (1) JPH08231546A (fr)
KR (1) KR960029335A (fr)
CN (1) CN1138583A (fr)
AR (1) AR002704A1 (fr)
AU (1) AU4097796A (fr)
BG (1) BG61729B1 (fr)
BR (1) BR9600149A (fr)
CA (1) CA2167349A1 (fr)
CO (1) CO4700524A1 (fr)
CZ (1) CZ16896A3 (fr)
DE (1) DE19501480A1 (fr)
EE (1) EE9600020A (fr)
FI (1) FI960226A (fr)
HR (1) HRP960009A2 (fr)
HU (1) HUP9600107A3 (fr)
IL (1) IL116771A (fr)
MA (1) MA23779A1 (fr)
NO (1) NO960221L (fr)
NZ (1) NZ280829A (fr)
PE (1) PE10597A1 (fr)
PL (1) PL312353A1 (fr)
SG (1) SG47379A1 (fr)
SK (1) SK7696A3 (fr)
SV (1) SV1996000004A (fr)
TN (1) TNSN96005A1 (fr)
TR (1) TR199600701A2 (fr)
YU (1) YU2896A (fr)
ZA (1) ZA96399B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
US7501409B2 (en) * 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
CN100372536C (zh) * 2001-02-15 2008-03-05 田边三菱制药株式会社 在口腔中迅速崩解的片剂
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
EP1454897B1 (fr) * 2001-12-13 2007-10-10 Asubio Pharma Co., Ltd. Derives de pyrazolopyrimidinone possedant une activite inhibitrice de pde7
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
JP2005527586A (ja) * 2002-04-05 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド 置換アリールアミド
EP3157520B1 (fr) 2014-06-23 2019-09-04 Celgene Corporation Utilisation d'aprémilast pour le traitement d'une maladie hépatique ou d'une anomalie de la fonction hépatique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (fr) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Derives de purinone utilises comme bronchodilatateurs,vasodilatateurs et agents anti-allergiques
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
EE9600020A (et) 1996-08-15
SV1996000004A (es) 1997-02-19
US5866571A (en) 1999-02-02
KR960029335A (ko) 1996-08-17
CZ16896A3 (en) 1996-08-14
HUP9600107A2 (en) 1997-05-28
TNSN96005A1 (en) 2005-03-15
HUP9600107A3 (en) 1999-06-28
FI960226A (fi) 1996-07-20
SK7696A3 (en) 1996-08-07
TR199600701A2 (tr) 1996-08-21
HU9600107D0 (en) 1996-03-28
IL116771A (en) 1999-06-20
DE19501480A1 (de) 1996-07-25
CA2167349A1 (fr) 1996-07-20
YU2896A (sh) 1999-03-04
NO960221D0 (no) 1996-01-18
EP0722943A1 (fr) 1996-07-24
AU4097796A (en) 1996-07-25
PL312353A1 (en) 1996-07-22
JPH08231546A (ja) 1996-09-10
NZ280829A (en) 1998-04-27
ZA96399B (en) 1996-08-14
AR002704A1 (es) 1998-04-29
CN1138583A (zh) 1996-12-25
HRP960009A2 (en) 1997-12-31
PE10597A1 (es) 1997-06-13
BG100291A (bg) 1996-07-31
CO4700524A1 (es) 1998-12-29
NO960221L (no) 1996-07-22
SG47379A1 (en) 1998-04-17
IL116771A0 (en) 1996-05-14
BR9600149A (pt) 1998-01-06
BG61729B1 (bg) 1998-04-30
FI960226A0 (fi) 1996-01-17

Similar Documents

Publication Publication Date Title
FI972970A (fi) Uusia yhdisteitä
DK1114817T3 (da) Substituerede benzylaminopiperidinforbindelser
ID16345A (id) Senyawa-senyawa heterosiklik
FI20030370A (fi) Uusia yhdisteitä
BR9612465A (pt) Compostos heterocíclicos
BR9509760A (pt) Composto
EE200000321A (et) Uudsed ühendid
ID24571A (id) Senyawa tienopirimidin
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
BR9600251A (pt) Composto
MA23779A1 (fr) Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones
EE9800172A (et) Ühendid
NO974170D0 (no) Polyazacykloalkan-forbindelser
BR9607487A (pt) Composição herbicida
BR9601295A (pt) Composto
ID20635A (id) Senyawa metalosen
BR9611576A (pt) Composto
ID18956A (id) Senyawa-senyawa herbisida
DE69620322D1 (de) Asymmetrische Triphenylendioxazinverbindungen
SE9702775D0 (sv) Novel compounds
SE9503561D0 (sv) New Compounds
BR1100842A (pt) Compostos
ITMI950031A0 (it) Composti dibenzoalchilenici
SE9502559D0 (sv) Novel compounds
DK0851865T3 (da) Hidtil ukendte heterocykliske forbindelser